Shortage of key COVID drug remdesivir fuels illegal trade in India
The U.S. government's deal to buy up most of the world's remdesivir has left many countries short, forcing families to pay up to 10 times the market price, if they can.
Watch CBS News
The U.S. government's deal to buy up most of the world's remdesivir has left many countries short, forcing families to pay up to 10 times the market price, if they can.
More formal studies provide a better understanding of how to treat COVID-19.
Physicians say federal rules for distributing the COVID-19 drug are unclear, leaving some hospitals in the lurch.
Terry Shaw says his hospital system is well-equipped with PPE, staff and key medications, including remdesivir, to care for patients.
The South is facing a dire situation, as coronavirus cases across the country hit a record high. Janet Shamlian reports.
A five-day treatment of remdesivir, one of two known drugs proven to help treat COVID-19, will cost $3,120 for a typical U.S. patient with commercial insurance. Gilead Sciences, the drugmaker, has promised a lower “government price,” but that excludes Medicare and Medicaid. Dr. Shoshana Ungerleider joined CBSN to discuss the potential impact.
COVID-19 treatment's price will depend on whether private insurers or government programs like Medicaid are paying.
More than a dozen states across the U.S. are seeing an increase in confirmed coronavirus cases, and some are reporting record spikes. Dr. Bob Lahita joined CBSN to discuss how we can stay safe as states open up.
The drug, manufactured by Gilead, was found to have shortened the recovery time for hospitalized coronavirus patients.
As the drug remdesivir has been shown to modestly shorten recovery time from the coronavirus, researchers at Emory University Hospital in Atlanta are adding even more fire power to the battle against the virus. Dr. Jon LaPook takes a look.
"What the remdesivir does is it stops the spark — and the immune modulator will hopefully be putting ash or putting dirt on the fire to put it out," one doctor said.
The National Institutes of Health say researchers have begun testing a potential coronavirus vaccine. Meanwhile, another blend of drugs designed to fight COVID-19 has entered a new phase. Dr. Jon LaPook has the latest in CBS News' "Racing to a Cure" series.
A drug that may shorten the recovery time of hospitalized coronavirus patients is being hailed as a potential breakthrough in the fight against the pandemic. Dr. Anthony Fauci lauded the drug remdesivir's "positive effect in diminishing the time to recovery" for patients in a clinical trial. While the drug is not yet approved, President Trump urged the FDA to get through the process as soon as possible. Ben Tracy reports from the White House, where daily task force briefings have been replaced with economy-focused events.
An experimental drug is showing promise in treating the coronavirus. Preliminary results from a clinical trial carried out by the National Institutes of Health found patients taking remdesivir recovered an average of four days sooner than those on a placebo. The FDA may now consider an emergency approval to allow for broad use of the drug, though the findings still need to be peer-reviewed. Dr. Tara Narula spoke to a patient in that study, and a scientist fighting to get more answers.
Dr. David Agus on potential breakthroughs in the race for treatments for the coronavirus. A clinical trial shows the antiviral drug, remdesivir, shortens the recovery time of hospitalized COVID-19 patients. And Oxford University scientists think they may have a vaccine by September.
Protests erupted in Chicago over stay-at-home orders. Similar frustration is boiling over in Charlotte, North Carolina. Janet Shamlian reports.
In the race to find a cure for COVID-19, doctors are looking at treatments for HIV patients. Dr. Stephen Parodi, national infectious disease leader for Kaiser Permanente, explains to CBSN's Reena Ninan why those medications stand out, why the antiviral drug remdesivir matters, and what to expect this flu season.
The FDA has granted emergency authorization for a coronavirus antibody test from Roche that claims to be 100% accurate in finding antibodies in blood and 99.8% accurate in detecting the lack of antibodies. Dr. Shoshana Ungerleider joined CBSN to discuss that plus other developments in fighting the pandemic.
Daniel O'Day says the drug will soon be deployed to the "most urgent" patients following the drug's emergency use authorization Friday.
Daniel O'Day said on "Face the Nation" that Gilead has donated its entire supply of remdesivir to be administered to hospitalized COVID-19 patients.
Missed the second half of the show? The latest on the coronavirus vaccine remdesivir, the future on air travels, coronavirus job losses and the latest sexual assault allegations against Joe Biden.
The following is a transcript of an interview with Gilead Sciences CEO Daniel O'Day that aired Sunday, May 3, 2020, on "Face the Nation."
While Remdesivir is seen as a step forward in treating COVID-19, we are still far from a cure or vaccine
The drug, produced by Gilead Sciences, may shorten the time it takes seriously ill patients to recover from COVID-19.
Hopes are high for antiviral drug after a clinical trial showed promise, but the benefits may be limited, experts say.
Meanwhile, a search-and-rescue mission for a downed fighter jet crew member is ongoing as the war in the Middle East rages on.
The government's legal bid to continue East Wing construction has the hallmarks of President Trump's social media posts.
Janice Randle was found dead in her bed in 1992, but police couldn't make an arrest in the case until new information emerged.
Washington, D.C., first responders said the building's structural integrity will be assessed once the bus is removed.
The incident comes after a string of similar nighttime attacks across Europe that have heightened concerns over antisemitism.
A key senator is demanding the TSA reverse its decision to let travelers keep their shoes on while passing through airport screening, a controversial policy at the center of a classified security warning.
U.S. officials confirmed that an F-15E fighter jet went down over Iran.
The executive order is designed to increase the NCAA's control over college sports, and threatens to remove federal funding for colleges and universities that don't comply with NCAA rules.
Officials from 23 states and the District of Columbia filed a lawsuit seeking to block President Trump's executive order that aims to restrict mail voting.
Washington, D.C., first responders said the building's structural integrity will be assessed once the bus is removed.
Frontenac, Kansas had everything it needed – except a public library. A mysterious donation changed that
The government's legal bid to continue East Wing construction has the hallmarks of President Trump's social media posts.
Janice Randle was found dead in her bed in 1992, but police couldn't make an arrest in the case until new information emerged.
UConn, on a 54-game winning streak, entered the Final Four undefeated for the ninth time in school history.
Goolsbee, president of the Federal Reserve Bank of Chicago, said mounting inflation risks "complicates the picture" on interest rates.
U.S. consumers are starting to feel the financial impact of the Iran war. Here's how the conflict is seeping into the economy.
The eye drops — sold under multiple brands — have been recalled over concerns about sterility, according to the FDA.
Hiring was much stronger than expected in March, with employers adding roughly three times the number of jobs economists predicted.
United did not say why it was raising its prices, but the move follows JetBlue also hiking its checked bag fees earlier this week, citing "rising operating costs."
The government's legal bid to continue East Wing construction has the hallmarks of President Trump's social media posts.
President Trump ordered the Department of Homeland Security to find a way to pay "each and every employee" of the agency.
In an interview with CBS News' Ed O'Keefe, Moore said President Trump has yet to articulate what the U.S. is doing in Iran.
Officials from 23 states and the District of Columbia filed a lawsuit seeking to block President Trump's executive order that aims to restrict mail voting.
The executive order is designed to increase the NCAA's control over college sports, and threatens to remove federal funding for colleges and universities that don't comply with NCAA rules.
"CBS Saturday Morning" looks at an experimental treatment for amyotrophic lateral sclerosis, or Lou Gehrig's disease, that is bringing hope to some patients suffering from the neurodegenerative disease. To inquire about possible participation in Silence ALS, an initiative to develop individualized gene-based therapies for patients with other rare genetic forms of ALS, please write to silenceals@cumc.columbia.edu.
John Cantrell was enjoying his retirement until an unexpected condition forced him to choose between two kinds of heart surgery.
The Environmental Protection Agency also added microplastics to its contaminant candidate list for the first time.
The FDA approved a new GLP-1 drug from Eli Lilly. Dr. Jon LaPook breaks it down.
The COVID-19 variant BA.3.2, nicknamed "Cicada," has been detected in at least 23 countries and half the states in the U.S.
The attacks came as Ukrainian President Volodymyr Zelenskyy traveled to Istanbul for talks with Turkish President Recep Tayyip Erdogan.
The incident comes after a string of similar nighttime attacks across Europe that have heightened concerns over antisemitism.
Videos broadcast by local television stations showed a large crowd of fans in the south stands amidst an explosion of fireworks.
Pope Leo XIV carried a wooden cross for all of the 14 stations of the Way of the Cross at the Colosseum on his first Good Friday as pontiff, marking the first time in decades that a pope carried the cross to every station.
In an interview with CBS News' Ed O'Keefe, Moore said President Trump has yet to articulate what the U.S. is doing in Iran.
Kenan Thompson sits down with Kelly O'Grady to reflect on his career and parenthood while discussing his new children's book "Unfunny Bunny."
Alabama native Drayton Farley was working at a local auto plant and making bedroom recordings just a few years ago. Now he's being compared to Americana greats like Tyler Childers and Jason Isbell. His new album, "A Heavy Duty Heart," is out now. Here's Drayton Farley performing "It's Called Doubt."
Alabama native Drayton Farley was working at a local auto plant and making bedroom recordings just a few years ago. Now he's being compared to Americana greats like Tyler Childers and Jason Isbell. His new album, "A Heavy Duty Heart," is out now. Here's Drayton Farley performing "The Luckier Ones."
Alabama native Drayton Farley was working at a local auto plant and making bedroom recordings just a few years ago. Now he's being compared to Americana greats like Tyler Childers and Jason Isbell. His new album, "A Heavy Duty Heart," is out now. Here's Drayton Farley performing "I Need Your Love."
Mumford & Sons' new record, "Prizefighter," recently debuted in the top 10 of the Billboard Hot 200. The band spoke to Anthony Mason about their journey through the music industry, how they got their confidence back and the major collaborations on their new music.
"CBS Mornings" sits down with Tristan Harris, co-founder and president of the Center for Humane Technology, who is featured in the 2026 documentary, "The AI Doc: Or How I Became an Apocaloptimist."
CBS News contributor Patrick McGee joins "The Daily Report" to discuss the codependent relationship between Apple and China, a country that manufactures hundreds of millions of iPhones every year.
From labor shortages to environmental impacts, farmers are looking to AI to help revolutionize the agriculture industry. One California startup, Farm-ng, is tapping into the power of AI and robotics to perform a wide range of tasks, including seeding, weeding and harvesting.
The JPMorgan Chase CEO said the bank may one day introduce prediction market features, but said "there's a bunch of stuff we won't do" in that space.
Many have dreamed of a future with flying cars, eliminating traffic on the morning commute. One company is trying to make that dream a reality. Itay Hod reports.
NASA's Artemis II astronauts will spend about 24 hours orbiting the Earth and running checks on their spacecraft and life support systems before heading to the moon.
Four astronauts are traveling around the moon on Artemis II, going further from Earth than anyone before. CBS News' Mark Strassmann and Peter King have more.
Former NASA astronaut Clayton Anderson joins CBS News to discuss what the Artemis II astronauts will do as they orbit the Earth after takeoff.
Members of the Artemis II crew will be the first people to sleep inside the Orion spacecraft. CBS News' Kris Van Cleave has more on how they'll do that.
The science and technology behind using the restroom in space continues to evolve. CBS News senior transportation correspondent Kris Van Cleave looks at the out-of-this-world facilities available to the Artemis II crew.
Janice Randle was found dead in her bed in 1992, but police couldn't make an arrest in the case until new information emerged.
On April 3, 1996, the FBI arrested Theodore Kaczynski in the Unabomber case, ending one of the longest and most intense manhunts in U.S. history. Watch CBS News' coverage from that day.
President Trump's firing of Attorney General Pam Bondi is raising questions about their dynamic in the months prior. CBS News' Weijia Jiang reports.
A mother and daughter are accused of killing a man by poisoning his root beer float. CBS News' Peter Van Sant reports.
Golf icon Tiger Woods told officers at the scene of a Florida car crash where he was arrested for DUI that he was "just talking to the president." It's unclear if Woods was referring to President Trump. CBS News' Nicole Valdes reports.
The Artemis II astronauts continued their long coast to the moon, capturing stunning photos along the way.
The photo shows the entire planet, as well as the Northern and Southern lights.
The engine firing provided a slingshot-like boost to the Orion capsule, speeding it to 24,500 mph, the velocity needed to break free of Earth's gravitational clasp for a trek to the moon.
NASA's Artemis II astronauts will spend about 24 hours orbiting the Earth and running checks on their spacecraft and life support systems before heading to the moon.
NASA's Artemis II astronauts launched on a nine-and-a-half-day mission around the moon and back.
A look back at the esteemed personalities who've left us this year, who'd touched us with their innovation, creativity and humanity.
Does the evidence show a cover-up, or was Todd Kendhammer wrongfully convicted for the murder of his wife?
Christy Salters-Martin dominated in the boxing ring but faced her toughest challenger at home.
Family seeks answers in death of newlywed who disappeared in 2005 while on Mediterranean honeymoon cruise.
Meet the tattooed beauty charged in the death of Google executive Forrest Hayes.
Meet the woman who rescued a piece of the Oscars in a dumpster. Plus, we take a trip to Hollwyood to learn about the history of America's iconic film industry.
"CBS Saturday Morning" visits Jollof Bowl, which is bringing West African flavors to Baltimore.
Kenan Thompson sits down with Kelly O'Grady to reflect on his career and parenthood while discussing his new children's book "Unfunny Bunny."
Frontenac, Kansas, is a community of 3,000 residents. When its city administrator received a mysterious $4.6 million dolllar donation from a couple whose dying wish was for a library to be built, the town sprung into action to solidify its legacy.
The ceiling of the Sistine Chapel features one of the world's most famous art pieces painted by Michelangelo in the early 1500s. "CBS Saturday Morning" gets a behind-the-scenes look at how the masterpiece stays vibrant after 500 years.